Coeptis Therapeutics
COEP
COEP
38 hedge funds and large institutions have $58.9M invested in Coeptis Therapeutics in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
+8
Holders Change %
+26.67%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
10
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
D.E. Shaw & Co
New York
|
+$4.46M |
2 |
CM
Cohanzick Management
Pleasantville,
New York
|
+$2.1M |
3 |
MSU
Mizuho Securities USA
New York
|
+$2.03M |
4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$1.8M |
5 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
+$1.58M |
Top Sellers
1 |
GCL
Glazer Capital LLC
New York
|
-$9.15M |
2 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$4.1M |
3 |
Citadel Advisors
Miami,
Florida
|
-$89.5K |
4 |
ICM
Ionic Capital Management
New York
|
-$50K |
5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$22.3K |